Team:UC Chile2/Cyanolux/Project

From 2012.igem.org

(Difference between revisions)
Line 100: Line 100:
<h3>pSB1C3_IntK</h3> [http://partsregistry.org/Part:BBa_K743006 BBa_K743006]
<h3>pSB1C3_IntK</h3> [http://partsregistry.org/Part:BBa_K743006 BBa_K743006]
-
<br />
+
<p>This construct is an integrative plasmid which targets neutral recombination sites (slr0370 and sll0337). We selected this locus because it has been extensively used in the literature (REFERENCE) and it shown to have no deleterious effects on Synechocystis viability. We selected Kanamycin resistance as our transformation marker. [PUT LINK TO CONSTRUCT HERE].</p>
-
<p>This constructs is an integrative plasmid which targets neutral recombination sites (slr0370 and sll0337). We selected this locus because it has been extensively used in the literature (REFERENCE) and it shown to have no deleterious effects on Synechocystis viability. We selected Kanamycin resistance as our transformation marker. [PUT LINK TO CONSTRUCT HERE].</p>
+
<br>
<br>
Using this backbone we have decided to put LuxAB under the transaldolase promoter.We have choose the transaldolase promoter to express the luciferase part of the operon, as in the literature the promoter is described as having a peak of expression at 2 hours past dusk, which we believe is just the right timing to "turn on the lamp".
Using this backbone we have decided to put LuxAB under the transaldolase promoter.We have choose the transaldolase promoter to express the luciferase part of the operon, as in the literature the promoter is described as having a peak of expression at 2 hours past dusk, which we believe is just the right timing to "turn on the lamp".

Revision as of 03:10, 24 September 2012

Project: Luxilla - Pontificia Universidad Católica de Chile, iGEM 2012